SavedAdd your journal

Journals / Turkish Journal of Biology / 2016 / Cilt: 40 - Sayı: 6

The sensitivity of 5-formylcytosine to doxorubicin regardless of DNA damage

Selcen UZUNER ÇELİK
Chris O'NEILL
Pages
1251–1257
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results suggest preliminary information on how healthy noncancerous cells can response to chemotherapeutics in terms of cytosine modifications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We have previously shown that DNA damage induced by doxorubicin was associated with an increase in the level of DNA methylation, 5meC, in mouse embryonic fibroblasts using a developed immunostaining methodology.
📊
Key Findings & Data:Cytosine modifications are dynamically regulated in the genome during lifespan, but abnormal changes in the 5meC pattern can be associated with diseases in particular cancer progressions and DNA damage.
💡
Conclusion & Impact:The results suggest preliminary information on how healthy noncancerous cells can response to chemotherapeutics in terms of cytosine modifications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We have previously shown that DNA damage induced by doxorubicin was associated with an increase in the level of DNA methylation, 5meC, in mouse embryonic fibroblasts using a developed immunostaining methodology. Doxorubicin (also known as adriamycin), which induces double-strand DNA breaks, has been widely used in cancer therapy. Cytosine modifications are dynamically regulated in the genome during lifespan, but abnormal changes in the 5meC pattern can be associated with diseases in particular cancer progressions and DNA damage. One of the side effects of cancer therapy is that chemotherapeutic agents can damage healthy cells as well as cancerous cells. In this study, we aimed to investigate (i) the effect of doxorubicin at a dose that does not induce DNA damage on cytosine modifications 5meC, 5hmC, and 5fC, and (ii) the effect of a treatment known to be nongenotoxic (room light) on 5meC, 5hmC, and 5fC. We found that 5fC is the most sensitive modification to each treatment experienced in healthy fibroblasts as its level decreased after each condition, and its decrease did not correlate to DNA damage. The results suggest preliminary information on how healthy noncancerous cells can response to chemotherapeutics in terms of cytosine modifications.

🔖

Cite This Article

ÇELİK, S. U., O'NEILL, C. (2022). The sensitivity of 5-formylcytosine to doxorubicin regardless of DNA damage. Turkish Journal of Biology, Cilt: 40 - Sayı: 6, 1251–1257. https://ajindex.com/articles/600412

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Bachman M, Uribe-Lewis S, Yang XP, Burgess HE, Iurlaro M, Reik W, Murrell A, Balasubramanian S (2015). 5-Formylcytosine can be a stable DNA modification in mammals. Nat Chem Biol 11: 555-557.
  2. Bachman M, Uribe-Lewis S, Yang XP, Williams M, Murrell A, Balasubramanian S (2014). 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat Chem 6: 1049-1055.
  3. Booth MJ, Marsico G, Bachman M, Beraldi D, Balasubramanian S (2014). Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution. Nat Chem 6: 435-440.
  4. Chen Y, Jungsuwadee P, Vore M, Butterfield DA, Clair DKS (2007). Collateral damage in cancer chemotherapy - oxidative stress in nontargeted tissues. Mol Interv 7: 147-156.
  5. Christensen B, Houseman A, Marsit C, Zheng S, Wrensch M, Wiemels J, Nelson H, Karagas M, Padbury J, Raphael B et al. (2009). Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5: e1000602. Cortellino S, Xu JF, Sannai M, Moore R, Caretti E, Cigliano A, Le Coz M, Devarajan K, Wessels A, Soprano D et al. (2011). Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146: 67-79.
  6. Çelik S, Li Y, O'Neill C (2014). The exit of mouse embryonic fibroblasts from the cell-cycle changes the nature of solvent exposure of the 5′-methylcytosine epitope within chromatin. PloS One 9: e92523. Çelik S, Li Y, O'Neill C (2015). The effect of DNA damage on the pattern of immune-detectable DNA methylation in mouse embryonic fibroblasts. Exp Cell Res 339: 20-34.
  7. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan GP (2010). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13: 423-430.
  8. Globisch D, Munzel M, Muller M, Michalakis S, Wagner M, Koch S, Bruckl T, Biel M, Carell T (2010). Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 5: e15367. Hata K, Okano M, Lei H, Li E (2002). Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 129: 1983-1993.
  9. Illingworth RS, Gruenewald-Schneider U, Webb S, Kerr ARW, James KD, Turner DJ, Smith C, Harrison DJ, Andrews R, Bird AP (2010). Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet 6: e1001134. Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Esteve PO, Feng SH, Stroud H,